SNORA47 and non-small cell lung carcinoma: These findings highlight the therapeutic potential of targeting snoRNAs, such as SNORA47, and the possibility of SNORD33 and SNORD76 serving as biomarkers for NSCLC diagnosis; however, additional research is needed to validate their clinical applicability.